A commonly prescribed drug used to treat attention-deficit/hyperactivity disorder (ADHD) disproportionately affects the development of children’s brains compared to adults with ADHD, according to a new study published in Radiology.

Ambra Health, makers of the leading cloud-based, medical image management suite, today announced a new collaboration with Google Cloud to advance healthcare research with anonymized medical imaging data.

Tracking the fate of 200 unsolicited manuscripts rejected in one calendar year by the American Journal of Roentgenology, a researcher has found that the majority—117 manuscripts, close to 60 percent—eventually found a home in other scientific journals, according to an analysis running in the June edition of that very journal. 

Architectural distortion, the non-mass but potentially ominous clinical feature observed in many breast imaging procedures, is less likely to signal malignancy when it’s detected on screening mammography rather than diagnostic mammography or when it does not correlate with a subsequent targeted ultrasound exam.

Cocaine addiction can ruin a person physically and financially, and with an estimated 1.4 million cocaine users in the U.S., thousands will become trapped by their habit. While previous research on the drug and its addictive potential were observational and subjective, imaging is reshaping how we see addiction—and how it will be treated.

PET with 11C-PIB provides a noninvasive method for visualizing amyloid deposits in the heart, according to a study published in the February issue of the Journal of Nuclear Medicine. The researchers suggest that 11C-PIB eventually may be used in the clinical setting as both a diagnostic tool and a treatment follow-up method.

Optical coherence tomography (OCT) developer LightLab Imaging has launched its C7XR FD-OCT imaging system with the C7 Dragonfly Imaging Catheter at EuroPCR 2009 in Barcelona, Spain.

Two-year data from the SPIRIT III trial, Abbott’s U.S. pivotal trial,demonstrated that its Xience V everolimus-eluting coronary stent systemcontinues to deliver clinically superior benefits compared to BostonScientific’s Taxus paclitaxel-eluting coronary stent system, accordingto a presentation at a late-breaking clinical trials session at EuroPCR2008 in Barcelona, Spain.